THE OVARIAN CANCER RESEARCH FUND INC
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$10,047,998
Contributions
83%
Investments
10%
Program Services
3%
Other
2%
Fundraising Events
2%
Government Grants
0%
Membership Dues
0%
Expenses in 2024
$13,556,516
Grants
47%
Salaries & Benefits
21%
Fees to Service Providers
11%
Other
10%
Offices, Occupancy & IT
8%
Advertising & Promotion
2%
Depreciation
<1%
Benefits to Members
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$10,395,812
$8,342,303
-20%
Government Grants
$0
$0
-
Fundraising Events
$1,160,499
$195,891
-83%
Program Services
$438,937
$301,023
-31%
Membership Dues
$0
$0
-
Investments
$1,095,100
$992,906
-9%
Other
$352,167
$215,875
-39%
Total Revenues
$13,442,515
$10,047,998
-25%
Expenses
2023
2024
Change
Grants
$8,117,910
$6,428,064
-21%
Benefits to Members
$0
$0
-
Salaries & Benefits
$3,064,716
$2,887,953
-6%
Fees to Service Providers
$840,050
$1,549,931
+85%
Advertising & Promotion
$103,007
$251,942
+145%
Offices, Occupancy & IT
$738,208
$1,104,186
+50%
Interest
$0
$0
-
Depreciation
$0
$12,375
-
Other
$888,869
$1,322,065
+49%
Total Expenses
$13,752,760
$13,556,516
-1%
Net income
2023
2024
Change
Net income
-$310,245
-$3,508,518
-1031%
Functional Expenses
Summary
2023
2024
Change
Program
$11,116,441
$9,918,693
-11%
Admin
$1,220,617
$2,212,232
+81%
Fundraising
$1,415,702
$1,425,591
+1%
Total Expenses
$13,752,760
$13,556,516
-1%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)